Summit Therapeutics awards 100,000-unit stock grant

The award is scheduled to vest on October 8, 2029, subject to continued employment; each vested unit entitles the chief accounting officer to one common share.

Rhea-AI Filing Summary

On October 8, 2026, Summit Therapeutics Inc. Chief Accounting Officer Bhaskar Anand received a grant of 100,000 restricted stock units under the company's Amended and Restated 2020 Stock Incentive Plan. The units vest on October 8, 2029, subject to his continued employment, and each vested unit entitles him to one common share. His direct holdings after the grant were 261,047 shares, including shares previously acquired through the employee stock purchase plan.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Anand Bhaskar

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 261,047 shares (Direct)

Footnotes (2)

1. F1. Restricted stock units granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan. The restricted stock units vest on October 8, 2029, subject to the Reporting Person continuing his employment with the Issuer, and will entitle the Reporting Person to one share of the Issuer's common stock for each restricted stock unit that vests.
2. F2. Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.

Key Figures

Restricted stock units granted: 100,000 restricted stock units Direct holdings following grant: 261,047 shares Grant date: October 8, 2026 +2 more

5 metrics

Restricted stock units granted 100,000 restricted stock units Award under the Amended and Restated 2020 Stock Incentive Plan

Direct holdings following grant 261,047 shares Includes shares previously acquired through the employee stock purchase plan

Grant date October 8, 2026 Date of the restricted stock unit award

Vesting date October 8, 2029 Subject to continued employment

Shares per vested unit 1 common share per vested restricted stock unit Each unit that vests entitles the reporting person to one common share

Key Terms

Restricted stock units, Amended and Restated 2020 Stock Incentive Plan, employee stock purchase plan

3 terms

Restricted stock units financial

"Restricted stock units granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2020 Stock Incentive Plan financial

"under the Issuer's Amended and Restated 2020 Stock Incentive Plan"

employee stock purchase plan financial

"exempt transactions pursuant to the Issuer's employee stock purchase plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted stock units did SMMT's chief accounting officer receive?

Bhaskar Anand, Summit Therapeutics Inc.'s Chief Accounting Officer, received 100,000 restricted stock units on October 8, 2026, under the Amended and Restated 2020 Stock Incentive Plan. They vest on October 8, 2029, subject to his continued employment, and each vested unit entitles him to one common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/14/2026 - 04:07 PM EDT Accepted by SEC EDGAR 10/14/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Bhaskar

(Last) (First) (Middle)

C/O SUMMIT THERAPEUTICS INC.

601 BRICKELL KEY DRIVE, SUITE 1000

(Street)

MIAMI FLORIDA 33131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Summit Therapeutics Inc. [ SMMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/08/2026		A		100,000(1)	A	$0	261,047(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan. The restricted stock units vest on October 8, 2029, subject to the Reporting Person continuing his employment with the Issuer, and will entitle the Reporting Person to one share of the Issuer's common stock for each restricted stock unit that vests.

2. Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.

Remarks:

	/s/ Bhaskar Anand	10/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)